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Alterations in the extracellular matrix (ECM) production and remodeling of smooth muscle cells (SMCs)
have been implicated in processes related to the differentiation in atherosclerosis. Due to the anti-
atherosclerotic properties of the tetracyclines, we aimed to investigate whether cholesterol supple-
mentation changes the effect of doxycycline over the ECM proteins synthesis and whether isoprenylated
proteins and Rho A protein activation are affected. SMC primary culture isolated from chicks exposed to
atherogenic factors in vivo (a cholesterol-rich diet, SMC-Ch), comparing it with control cultures isolated
after a standard diet (SMC-C). After treatment with 20 nM doxycycline, [H3]-proline and [H3]-mevalonate
incorporation were used to measure the synthesis of collagen and isoprenylated proteins, respectively.
Real-time PCR was assessed to determine col1a2, col2a1, col3a1, ﬁbronectin, and mmp2 gene expression
and the pull-down technique was applied to determine the Rho A activation state. A higher synthesis of
collagens and isoprenylated proteins in SMC-Ch than in SMC-C was determined showing that doxycy-
cline inhibits ECM production and remodeling in both SMC types of cultures. Moreover, preliminary
results about the effect of doxycycline on protein isoprenylation and Rho A protein activation led us to
discuss the possibility that membrane G-protein activation pathways could mediate the molecular
mechanism.
© 2016 Japanese Pharmacological Society. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Tetracyclines have anti-atherosclerotic properties that are not
inherent to their bactericidal activity (1). Thus, they inhibit matrix
metalloproteinase (MMP) activity and are used to treat diseases
that involve tissue destruction (2). These compounds also inhibit
matrix degradation of abdominal aortic aneurysms (1,3), suppress
cellular proliferation and migration (4,5) and the synthesis of
extracellular matrix (ECM) and intimal hyperplasia (6,7). These
inhibitory effects have been attributed to the capacity of the tet-
racyclines to chelate divalent ions, but this only explains in parttry and Molecular Biology I,
da Fuentenueva s/n 18071,
49945.
rmacological Society.
. Production and hosting by Elsetheir inhibition of MMP activity due to the sequestering of the Zn2þ
needed for their function (1). Several studies have demonstrated
that tetracyclines inhibit MAPK and PI3K signaling pathways (5,8),
closely related to G proteins and membranes. These are two of the
most important signaling pathways in the development of
atherosclerosis andmay account for the tetracyclinesmechanism of
action in these processes, which has yet to be well characterized
and is one of the goals of this paper.
The signaling pathways involved in atherosclerosis include
isoprenylated proteins and small GTPases. A subfamily of these
proteins is Rho, which plays a key role in signaling pathways that
control proliferation, apoptosis, matrix adhesion and cell migration
(9e12). These processes are important for the physiology and
normal development of individuals and any deregulation of the
pathways in which these proteins are involved leads to a multitude
of pathological processes, including atherosclerosis (13). In smooth
muscle cell (SMC) contraction, Rho A is recognized as the main
regulator of the calcium sensitization of contractile proteins (14)vier B.V. This is an open access article under the CC BY-NC-ND license (http://
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regulation of serum-response factor (SRF)-dependent transcription
(15). SMC differentiation is marked by the expression of cytoskel-
etal and contractile proteins, coordinated by SRF (15), whose cell
localization is regulated by Rho A, which thereby modiﬁes the
expression of genes involved in cell differentiation (16). Various
studies have demonstrated that Rho A inhibition reduces the
expression of SMC differentiation marker genes (17).
In our laboratory, we are investigating changes in the ECM of
SMC in processes related to atherosclerosis, focusing on the effects
of cholesterol feeding on the expression of the major regulating
genes (18). In the present gene expression analysis, we used a chick
SMC primary culture model in which SMC were exposed to
atherogenic factors in vivo (cholesterol-rich diet, SMC-Ch),
comparing these cultures with control ones isolated after a stan-
dard diet (SMC-C) (19). Our objective was to investigate the effects
of doxycycline on ECM production and remodeling in SMC-Ch and
SMC-C cultures as well as on isoprenylated proteins synthesis and
Rho A activation.
2. Materials and methods
2.1. Animals and treatment
The protocol for this study was approved by the University of
Granada (Spain) Animal Laboratory Service and chicks received
humane treatment in compliance with the Animal Research regu-
lations of the European Union. Newborn White Leghorn male
chicks (“Gallus domesticus”) were supplied by the same service.
The diet was started at hatching and maintained until the chicks
were killed with food and water available ad libitum. Two groups of
10-day-old chicks were used: control diet group (C-group) kept on
a standard diet (Sanders A-00), and treated group (Ch-group) fed
on the same diet homogeneously mixed with 5% w/w powdered
cholesterol (Panreac reagent Barcelona, pure grade). After the
treatments, animals were anesthetized with ketamine (60 mg kg1
of body weight) and sodium pentobarbital (50 mg kg1 of body
weight) in compliance with the European Union Animal Research
rules.
2.2. SMC separation and culture
SMC were isolated from the aortic arch of the chicks, as previ-
ously described (20,21) with slight modiﬁcations (19) and cultured
in Dulbecco's Modiﬁcation of Eagle's Medium (DMEM) supple-
mented with D-glucose (4.5 g/l), L-glutamate (0.584 g/ml) (Flow),
antibiotic cocktail composed of penicillin (100 mg/ml) and
amphotericin (0.25 mg/ml) (Sigma), and 10% (v/v) fetal bovine
serum (FBS). Media were buffered with bicarbonate and cultures
were kept at 37 C in humidiﬁed atmosphere (95% air/5% CO2).
Media were renewed three times weekly. Secondary cultures were
initiated after low or high passages using 0.05%/0.02% Trypsin-
EDTA solution. All experiments were conducted using 3 or 4 pas-
sages. Cells were identiﬁed as vascular SMC by their hill-and-valley
conﬁguration at conﬂuence (21) and their positive ﬂuorescence
staining for smooth muscle actin and myosin (22). SMC cultures
obtained from control-diet fed chicks were designated as SMC-C,
and SMC cultures obtained from chicks fed with the control diet
supplemented with 5% cholesterol as SMC-Ch.
2.3. In vitro treatments of cultures
All in vitro treatments were performed in SMC cultures at 90%
conﬂuence, when ECM synthesis in SMC started to be evident.
Doxycycline (D9891, Sigma) was diluted in culture medium at aconcentration of 10 mg ml1 (20 nM), at which no toxicity or vari-
ation in primary cultured SMC proliferation has been reported, as
well as in other cell lines (23e25) and the incubation timewas 48 h.
2.3.1. [H3]-proline incorporation
The amount of SMC-synthesized collagen was determined by
the Peterkofsky method (26). SMC-C and SMC-Ch were seeded at
equal cell density in 6-well plates and, when conﬂuence reached
90%, 1 ml culture medium was added to each well containing
3.7$104 Bq L-[5-H3]-proline (9.62$1011 Bq/mmol) (Amersham,
Buckinghamshire, UK). After 48 h incubation, cells were lysed with
0.5 ml 0.5 M NaOH for 1 h. The resulting solution was neutralized
with an equal amount of 0.5 MHCl, and 50 ml were used tomeasure
total proteins with the Bradford method (27). One volume of 10%
TCAwas added to the remaining 250 ml and centrifuged at 13,000 g
for 15 min at 4 C. The resulting precipitate was dissolved in 100 ml
0.2 M NaOH, and then neutralized with 1 M HCl. The solution was
incubated with collagenase buffer (TriseHCl, pH 7.6 20 mM, and
CaCl2 250 mM ﬁnal concentration) and 10 units of collagenase
(Sigma) at 37 C overnight. Then, 150 ml 10% TCA were added and
centrifuged at 13000 g for 15 min at 4 C. The resulting supernatant
was added to 4 ml of scintillation ﬂuid (Cocktail Biogreen 3 for
liquid scintillation, Scharlau) and the radioactivity was measured in
a liquid scintillation counter LS 600 TA (Beckman Instruments).
2.3.2. [H3]-mevalonate incorporation
SMC and SMC-Ch were seeded in 12-well culture plates at equal
cell density. When cells reached 90% conﬂuence, the medium was
removed and 1 ml fresh culture medium containing 3.7$104 Bq
[H3]-mevalonate was added to each well. [H3]-mevalonate was
obtained from R,S-[2-H3] mevalonolactone (4.26$1010 Bq/mmol)
(Amersham). The process involved evaporating tritiated mevalo-
nolactone to dryness, hydrolyzing with NaOH 0.1 M at 37 C for 1 h
and neutralizing it with 0.1 M HCl and Hepes 100 mM pH 7.4. It was
then immediately used for the experiment. After the 48 h incuba-
tion with tritiated mevalonate, cells were lysed with 200 ml 0.1 M
NaOH at 4 C overnight. A 100 ml aliquot was used to measure total
proteins with the Bradford method (27); 4 ml of scintillation ﬂuid
(Cocktail Biogreen 3 for liquid scintillation, Scharlau) were added to
the remaining 100 ml and radioactivity was measured in an LS 600
TA liquid scintillation counter (Beckman Instruments).
2.4. Real-time PCR analysis
Total RNA from primary SMC cells cultures was isolated with
TRIZOL reagent (Invitrogen). Single-stranded cDNA was synthe-
sized from 4 mg total RNA using Oligo (dT)12e18 and PowerScript™
reverse transcriptase (Clontech) in a ﬁnal reaction volume of 20 mL.
Real-time PCR was performed with the Fast Start DNA Master SYBR
Green I Kit (Roche) and Chromo4 PCR Detection System (Biorad).
For the Light Cycler reaction, a master mix of the following reaction
components was prepared to the indicated ﬁnal concentration:
12.6 ml H2O, 2.4 ml MgCl2 (4 mM), 1 ml forward primer (0.5 mM), 1 ml
reverse primer (0.5 mM), and 2.0 ml of the Fast Start DNA Master
SYBR Green I mix (Roche Diagnostic). 1 ml cDNA was added to 19 ml
Light Cycler master mix as PCR template. Table 1 contains the
primer sequences used in this study, optimized to an equal
annealing temperature of 55 C. Light Cycler products of the
different gene expressions were analyzed by agarose gel electro-
phoresis, and a Light Cycler melting curve was constructed to test
for a single product at the end of each PCR reaction. Real-time PCR
efﬁciencies were evaluated by using different starting amounts of
cDNA for gapdh, col1a2, col2a1, col3a1, ﬁbronectin, and mmp2
genes. These cDNAs were diluted (2.5$10e1; 5.0$10e2; 1$10e2;
2$10e3; 4$10e4; 8$10e5) and ampliﬁed. A mathematical model
Table 1
Chicken-speciﬁc real time PCR primers.
Gene Sense primer (50-30) Antisense primer (50-30) Amplicon size
gapdh TTCTACACACGGACACTTC CATCTTGGCTGGTTTCTC 109
col2a1 GGACTTGGTGGAAACTTTGC GTTGCCTTGAAATCCCTGG 139
mmp2 CAGGACAGATGGATACAGATGG AGGAAGATGAAGGGGAATACAC 140
col3a1 ATCTGTGTGTGTGACTCTGG GTTTTGTAGGCTGTGGTGTTG 86
ﬁbronectin CTGTGTATGCTGTAACTGGTC TGCTGATGCTGTTGTCCTG 89
Fig. 1. Effect of doxycycline on the incorporation of [H3]-proline into proteins sensitive
to collagenase hydrolysis (dpm/mg protein) in SMC-C and SMC-Ch (striped bars). Re-
sults are expressed as the mean ± SEM of at least three determinations (*P < 0.05).
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col1a2, col2a1, col3a1, ﬁbronectin, and mmp2 mRNA expression in
real-time PCR with respect to the reference gapdh gene transcript.
The cDNA of the genes studied in the different samples was diluted
1:100 and corresponded to the range in which the DNA quantity
ratio was linear in the efﬁciency curve. cDNAs were ampliﬁed as
described above to obtain the Cp value for each sample.
2.5. Determination of Rho A activation state
Rho A activation was measured in each sample by means of the
pull-down technique, using a commercially available kit (Rho A
activation assay Biochem Kit, Cytoskeleton). The process for sepa-
rating active and inactive Rho A fractions started with approxi-
mately 107 cells, using the kit reagents and protocol. 48 h after the
beginning of each treatment, lysis buffer was added and the plate
was scraped to obtain the maximum possible amount of extract. It
was then centrifuged at 10,000 g and 4 C for 2 min and the
sediment was discarded. Supernatant was divided in two fractions,
one to measure total Rho A and proteins (100 ml), and the other
(100 ml) to separate GTP-bound Rho A from GDP-bound Rho A.
50 mg of glutathione-bound resin were added to the latter aliquot
and incubated at 4 C for 1 h under agitation and then centrifuged
at 5000 g at 4 C for 1 min. Supernatant was removed and the
pellet was washed with 500 ml washing buffer and centrifuged at
5000 g for 3 min at 4 C. Supernatant was removed and 20 ml of
sample buffer (4% SDS, 20% glycerol, 10% 2-mercaptoethanol,
0.004% bromophenol blue, and 0.125 M TriseHCl, pH 6.8) were
added and heated at 100 C for 2 min. Semiquantitative measure-
ment of Rho A in each fraction was obtained by transferring to a
membrane using the dot-blot technique, measuring total protein
concentration in total Rho A fraction and standardizing total pro-
tein concentration to be identical in all samples (2 mgmL1). The
active Rho A fraction, in which the protein concentration cannot be
measured because of the resin interference, was standardized ac-
cording to the data obtained for the total Rho A fraction. Then, 2 mL
of sample were added to a nitrocellulose membrane and incubated
at 37 C for 1 h to ensure the blots were dry. Subsequently, the
membrane was blocked and incubated with the Rho A primary
antibody from the kit (ARH01, Cytoskeleton). Next, the membrane
was incubated with total anti-mouse Ig secondary antibody bound
to peroxidase (Sigma) at 1/5000 dilution for 1 h at room temper-
ature. The Immobilon Western Detection Reagents (Millipore)
chemiluminescence system was used for the detection, printed on
photographic paper (Konica Minolta). The resulting image was
digitized, and results were analyzed by densitometry with IMAGEJ
software (National Institutes of Health, USA).
2.6. Statistical analysis
Sigmaplot 10.0 and SigmaStat 3.5 for Windows (Systat Software
Inc., Richmond, CA, USA) were used for the statistical analyses.
Results are expressed as mean ± SEM. Data were analyzed by using
the one-way ANOVA test for multiple group comparisons with the
Bonferroni's Multiple Comparison Test. P  0.05 was consideredsigniﬁcant in all tests. P  0.05 was considered signiﬁcant in all
tests.
3. Results
3.1. Doxycycline effect on collagen synthesis
In order to determine whether collagen synthesis is affected in
the presence of doxycycline (20 nM), we assessed the proline
incorporation into proteins sensitive to collagenase hydrolysis.
Proline is one of the amino acids of which the collagen molecule is
largely formed. Therefore, [H3]-proline incorporation into proteins
sensitive to hydrolysis by collagenase can be used as a measure-
ment of collagen synthesis. This assay measures the secretion of
newly synthesized collagen types I and III, as well as ﬁbronectin
into the cell-culture medium (29). Fig. 1 shows the effect of doxy-
cycline on proline incorporation into SMC-C and SMC-Ch cultures.
Doxycycline strongly suppressed collagen synthesis in both types of
cultures. This suppression reduced proline incorporation into col-
lagens in SMC-Ch to levels similar to those found in SMC-C, indi-
cating that doxycycline effect is no dependent on intracellular
cholesterol content.
3.2. Effect of doxycycline on the expression of genes encoding
collagen types I, II, and III, ﬁbronectin and mmp2
The effect of cultures exposure to doxycycline on the ECM
proteins genes expression was measured by real-time PCR. Fig. 2
shows that the expression of col1a2; col2a1, col3a1 ﬁbronectin
and mmp2 are signiﬁcantly different between SMC-C and SMC-Ch
at P < 0.05 and that the effect of doxycycline on the expression of
col1a2; col2a1, col3a1 ﬁbronectin, and mmp2 genes with respect to
gapdh. Doxycycline strongly inhibited the expression of the ﬁve
genes studied. This effect was especially noticeable in SMC-Ch
Fig. 2. Variation of col1a2; col2a1, col3a1, ﬁbronectin, and mmp2 expression with respect to gapdh in SMC-C and SMC-Ch (striped bars) treated with doxycycline, represented as the
logarithm of this variation. Results are expressed as the mean ± SEM of at least three determinations (*P < 0.05; **P < 0.005; ***P < 0.0005).
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change the doxycycline effect vs control.
3.3. Effect of doxycycline on protein isoprenylation
To determine whether protein isoprenylation could mediate the
effect of doxycycline on SMC cultures, we measured the incorpo-
ration of [H3]-mevalonate into total protein. Fig. 3 shows that
Protein isoprenylation in non-treated SMC-Ch is signiﬁcantly
greater than protein isoprenylation in non-treated SMC-C and that
doxycycline reducedmevalonate incorporation into total protein byFig. 3. Effect of doxycycline on the incorporation of [H3]-mevalonate into total pro-
teins (dpm/mg protein) in SMC-C and SMC-Ch. Results are expressed as the
mean ± SEM of at least three determinations (*P < 0.05; **P < 0.005).35% in SMC-C and 40% in SMC-Ch, decreasing protein iso-
prenylation in SMC-Ch to values similar to those of SMC-C, indeed
there are not signiﬁcant differences between the protein iso-
prenylation in non-treated SMC-C and doxycycline treated SMC-Ch
cultures (P > 0.05).
3.4. Doxycycline effect on Rho A activation state
In order to determine whether G protein activation pathways
could mediate the doxycycline effects in SMC, Rho A activation was
measured as variation of active Rho A against total Rho protein in
SMC-C cultures. Rho A activation was measured in each sample by
means of the pull-down technique. Fig. 4 shows that doxycycline
inhibited by 70% the Rho A activation.
3.5. Effect of doxycycline on the expression of genes encoding
pparg, lxr, and srebp-1
Fig. 5 shows the effect of the doxycyclines on the mRNA
expression of ppar-g, lxr, and srebp-1 genes with respect to gapdh.
Doxycycline markedly increased the expression of the ppar-g gene
while inhibited the expression of the srebp-1 gene. The effect of
doxycycline over the lxr gene was not signiﬁcant (P > 0.05).
4. Discussion
Our group is investigating changes in SMC extracellular matrix
during atherosclerosis-related processes. Our results here show for
Fig. 4. Effect of doxycycline on Rho A activation. The graph shows luminescence
variation of active Rho A against total Rho in SMC-C cultures. Results are expressed as
the mean ± SEM of at least three determinations (*P < 0.05; **P < 0.005).
Fig. 5. Variation of srbp, pparg and lxr expression with respect to gapdh in SMC-C cell
cultures treated with doxycycline, represented as the logarithm of this variation. Re-
sults are expressed as the mean ± SEM of at least three determinations (*P < 0.05;
**P < 0.005).
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expression in SMC, especially affecting collagen synthesis and the
expression of collagens I, II, and III and ﬁbronectin genes. The
decrease in ECM protein synthesis in SMC is closely related to the
reduction in intimal thickening described in other studies (6). This
process involves not only SMC proliferation and migration (closely
related to MMPs) but also increased synthesis of ECM, which serves
as a scaffold for the growth and migration of the cells.
Previous works in our lab show that cholesterol supplementa-
tion to the diet of the chicks increased collagen synthesis, col1a2;
col2a1, col3a1 and ﬁbronectin gene expression (30), and the incor-
poration of [H3]-mevalonate into proteins in SMC-Ch versus SMC-C,
while this effect was reversed by treating the SMC-Ch cultures with
doxycycline.
The anti-atherosclerotic properties of tetracyclines have
prompted research into the prophylactic use of this drug in acutecardiac syndrome (31,32). With regard to the mechanism of action
involved, our results show that doxycycline blocks the incorpora-
tion of mevalonate into total proteinwhich leads to the inhibition of
protein isoprenylation and hence to the reduction of Rho A
activation.
The inhibitory effect of doxycycline on MMP activity in SMC is
well documented (23,24,33,34). However, little is known about its
impact on ECM production except for its inhibition of collagen and
prostaglandin G production in rat chondrocytes (35,36), which is
directly related to its effect in osteoarthrosis. The mechanism by
which doxycycline produces these effects has been attributed to the
ability of tetracyclines to chelate divalent ions (1) and also to the
inhibition of MAPK kinase pathways (5,8), closely related to
membrane G proteins, which may underlie the tetracyclines
mechanism of action in atherosclerosis. Our results have shown
that doxycycline inhibits protein isoprenylation and Rho A activa-
tion. Studies in our lab with lovastatin and other prenyltransferase
inhibitors show that activation of Rho A through isoprenylation, is
crucial for the regulation of ECM synthesis in SMC (37). Resembling
the effects of lovastatin studied in our lab we suggest the hypoth-
esis that the anti-atherogenic effects of doxycycline are related to
protein isoprenylation and G-protein activation pathways.
This study has demonstrated that doxycycline inhibits ECM
production in SMC cultures. The effect of doxycycline on protein
isoprenylation ([H3]-mevalonate incorporation) and membrane G-
protein activation pathways (Rho A activation) in SMC, could
indicate a hypothetic mechanism of their implication in athero-
sclerosis. Cholesterol supplementation of the chicks' diet increased
collagen and ﬁbronectin synthesis, at level of gene expression, as
well as increased the incorporation of [H3]-mevalonate into pro-
teins in SMC-Ch versus SMC-C, while these effects were reversed by
treating the SMC-Ch cultures with doxycycline. New studies would
be necessary to demonstrate the implication of the protein iso-
prenylation and G-protein activation pathways in the molecular
mechanism of the antiatherogenic effect of doxycycline.
The present results suggest that doxycycline activation of pparg
and inhibition of srbp-1 must exert an inﬂuence on numerous cell
processes. Given the anti-atherogenic and anti-inﬂammatory role
of these two transcription factors, they may mediate one of the
pathways by which doxycycline exerts its hypolipidemic effects. It
has been shown that SREBP-1 activation required signaling through
Rho A/Rho-kinase signaling (38,39). On the other hand, a link be-
tween the Rho A/ROCK activity and PPARg and the processes of
proliferation and vascular remodeling has also been established. In
this sense, the inhibition of the downstream effector of Rho A,
ROCK, was accompanied by an induction of the expression of pparg
and as a result, there was a reduction in the proliferation and
vascular remodeling (40). Previous studies in our labs show that
activation of Rho A throught isoprenylation, is crucial for the
regulation of ECM synthesis in SMC (37). This suggest that the anti-
atherogenic effects of doxycycline are related to protein iso-
prenylation and G-protein activation pathways and that it can be
mediated trough the modulation of important transcription factors
such as SREBPs and PPARg.
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